首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Acs chemical neuroscience

缩写:ACS CHEM NEUROSCI

ISSN:1948-7193

e-ISSN:1948-7193

IF/分区:3.9/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引4348
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Fatema Bhinderwala,Heidi E Roth,Mary Filipi et al. Fatema Bhinderwala et al.
Multiple sclerosis (MS) is a chronic and progressive neurological disorder without a cure, but early intervention can slow disease progression and improve the quality of life for MS patients. Obtaining an accurate diagnosis for MS is an ard...
Sean Chia,Rodrigo Lessa Cataldi,Francesco Simone Ruggeri et al. Sean Chia et al.
Oligomeric assemblies of the amyloid β peptide (Aβ) have been investigated for over two decades as possible neurotoxic agents in Alzheimer's disease. However, due to their heterogeneous and transient nature, it is not yet fully establishe...
Yachiyo Mitsuishi,Masaki Nakano,Hirotatsu Kojima et al. Yachiyo Mitsuishi et al.
Brain amyloid-β (Aβ) governs the pathogenic process of Alzheimer's disease. Clinical trials to assess the disease-modifying effects of inhibitors or modulators of β- and γ-secretases have not shown clinical benefit and can cause serious...
Vesa Halipi,Nima Sasanian,Julia Feng et al. Vesa Halipi et al.
Formation of amyloid-β (Aβ) fibrils is a central pathogenic feature of Alzheimer's disease. Cell-secreted extracellular vesicles (EVs) have been suggested as disease modulators, although their exact roles and relations to Aβ pathology re...
Juan Pablo Munafó,Brunella Biscussi,Diego Obiol et al. Juan Pablo Munafó et al.
Cholinergic deficit is a characteristic factor of several pathologies, such as myasthenia gravis, some types of congenital myasthenic syndromes, and Alzheimer's Disease. Two molecular targets for its treatment are acetylcholinesterase (AChE...
Qingfeng Wen,Mandy Melissa Jane Wittens,Sebastiaan Engelborghs et al. Qingfeng Wen et al.
Alzheimer's disease (AD) is the most common cause of dementia. New strategies for the early detection of MCI and sporadic AD are crucial for developing effective treatment options. Current techniques used for diagnosis of AD are invasive an...
Anastasiia A Stepanchuk,Peter K Stys Anastasiia A Stepanchuk
Protein misfolding has been extensively studied in the context of neurodegenerative disorders and systemic amyloidoses. Due to misfolding and aggregation of proteins being highly heterogeneous and generating a variety of structures, a growi...
Jeong Hyun Jeong,Haeun Lee,Doyoung Kim et al. Jeong Hyun Jeong et al.
In consideration of the limited number of FDA-approved drugs for autism spectrum disorder (ASD), significant efforts have been devoted to identifying novel drug candidates. Among these, 5-HT7R modulators have garnered considerable attention...
Allison L Germann,Yuanjian Xu,Douglas F Covey et al. Allison L Germann et al.
Activation of the GABAA receptor is associated with numerous behavioral end points ranging from anxiolysis to deep anesthesia. The specific behavioral effect of a GABAergic compound is considered to correlate with the degree of its function...
Mani Surya Kumar Palepu,Siva Nageswara Rao Gajula,Malleshwari K et al. Mani Surya Kumar Palepu et al.
Alteration of gut microbiota and microbial metabolites such as short-chain fatty acids (SCFAs) coexisted with stress-generated brain disorders, including depression. Herein, we investigated the effect of SCFAs in a treatment-resistant depre...